Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176655 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
A Phase 2 study, sponsored by Cady, Roger, M.D..
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
NCT02176655: Completed Phase 2 study, sponsored by Cady, Roger, M.D..
NCT02176655 is a Phase 2 study that has completed, run by Cady, Roger, M.D.. The registered enrollment target is 31 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02176655, a Phase 2 study, has completed, sponsored by Cady, Roger, M.D..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.
Primary Outcome
Headache severity 2 hours post treatment in sumatriptan succinate 12.5 mg and acetylsalicylic acid 325 mg (VVD-101) vs. placebo. Headache severity was measured on a 4 point Likert scale with 0 = no pain, 1 = mild pain, 2 = moderate, 3 = severe pain.
Interventions
- DRUG Placebo
- DRUG VVD-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
What the finished NCT02176655 record still lists
NCT02176655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02176655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02176655 about?
NCT02176655 is a clinical study titled "Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches". This study proposes to compare the efficacy of sumatriptan and aspirin to placebo as an acute abortive treatment for delayed alcohol induced headache in adult subjects.
What is the current status of trial NCT02176655?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2014-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02176655?
The interventions under investigation include: Placebo (DRUG), VVD-101 (DRUG).
Who is sponsoring clinical trial NCT02176655?
This trial is sponsored by Cady, Roger, M.D., which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02176655's enrollment target sits among peer trials
31 1578th of 2000 higher than 419 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia